Literature DB >> 9413195

The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells.

M Sato1, T Narita, N Kimura, K Zenita, T Hashimoto, T Manabe, R Kannagi.   

Abstract

BACKGROUND: The vascular endothelium plays a critical role in cancer metastasis by directing circulating cancer cells into extravascular tissues and by expressing cell adhesion molecules. The authors investigated the interaction between a cell line derived from human colon cancer and cultured murine endothelial cells, in vitro, and in vivo.
MATERIALS AND METHODS: Variant cell lines with high (WiDr-HA) or low (WiDr-LA) levels of cell surface sialyl Lewis(a) antigen (s-Le(a)) were isolated from the heterogeneous WiDr cells (WiDr-P) in order to characterize the biological behavior of colon cancer cells having elevated cell surface contents of s-Le(a).
RESULTS: A correlation was found to exist between the degree of s-Le(a) expression, and the attachment of cancer cells to activated human umbilical vein endothelial cells, or to F-2 cells isolated from murine vascular endothelial cells. The adhesion of WiDr-P and WiDr-HA to F-2 cells was inhibited by the addition of anti-s-Le(a) antibody (Ab). WiDr-P and WiDr-HA both demonstrated the capacity to metastasize to the liver, by the inoculation of cancer cells to the spleen, while WiDr-LA did not do so. The number of metastatic nodules of WiDr-HA was significantly higher than that of WiDr-P. Treatment with anti-s-Le(a) Ab inhibited the metastasis of WiDr-P and WiDr-HA to the liver, but not with anti-s-Le(x) Ab.
CONCLUSIONS: These findings suggest that s-Le(a) plays an important role in cell adhesion molecules, in the metastasis of colon cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413195

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

Review 2.  The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

3.  Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity.

Authors:  Ritsuko Sawada; Shu-Man Sun; Xiaohong Wu; Feng Hong; Govind Ragupathi; Philip O Livingston; Wolfgang W Scholz
Journal:  Clin Cancer Res       Date:  2011-02-22       Impact factor: 12.531

4.  Metastatic potential of human CX-1 colon adenocarcinoma cells is dependent on the expression of sialosyl Le(a) antigen.

Authors:  A Opolski; A Laskowska; J Madej; J Wietrzyk; A Kłopocki; C Radzikowski; M Ugorski
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

Review 5.  Are selectins involved in metastasis?

Authors:  T Krause; G A Turner
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

6.  The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation.

Authors:  Patrick Auguste; Lucia Fallavollita; Ni Wang; Julia Burnier; Andreas Bikfalvi; Pnina Brodt
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

7.  Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow.

Authors:  Susan N Thomas; Fei Zhu; Ronald L Schnaar; Christina S Alves; Konstantinos Konstantopoulos
Journal:  J Biol Chem       Date:  2008-03-27       Impact factor: 5.157

8.  Identification of a cDNA encoding a plant Lewis-type alpha1,4-fucosyltransferase.

Authors:  I B Wilson
Journal:  Glycoconj J       Date:  2001-06       Impact factor: 2.916

9.  Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells.

Authors:  Susan N Thomas; Ronald L Schnaar; Konstantinos Konstantopoulos
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-31       Impact factor: 4.249

10.  Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery may decrease recurrence rates for patients undergoing resections for pancreatic cancer, cholangiocarcinoma and metastatic colorectal cancer.

Authors:  Shreya Gupta; James D McDonald; Reed I Ayabe; Tahsin M Khan; Lauren A Gamble; Surajit Sinha; Cathleen Hannah; Andrew M Blakely; Jeremy L Davis; Jonathan M Hernandez
Journal:  J Gastrointest Oncol       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.